We can't say anything concrete about how Jacinta Nampijinpa Price voted on increasing access to medicinal cannabis products
How Jacinta Nampijinpa Price voted compared to someone who agrees that terminally ill people should be able to access medicinal cannabis products
Most important divisions relevant to this policy
These are the most important divisions related to the policy “for increasing access to medicinal cannabis products” which Jacinta Nampijinpa Price could have attended. They are weighted much more strongly than other divisions when calculating the position of Jacinta Nampijinpa Price on this policy.
| Division | Jacinta Nampijinpa Price | Supporters vote | ||||
|---|---|---|---|---|---|---|
| no votes listed | ||||||
Other divisions relevant to this policy
These are less important divisions which are related to the policy “for increasing access to medicinal cannabis products” which Jacinta Nampijinpa Price could have attended.
| Division | Jacinta Nampijinpa Price | Supporters vote |
|---|---|---|
8th Mar 2023, 6:27 PM – Senate Therapeutic Goods Amendment (2022 Measures No. 1) Bill 2022 - Second Reading - Affordable medicinal cannabis |
absent | Yes |
24th Nov 2022, 11:13 AM – Senate Narcotic Drugs (Licence Charges) Amendment Bill 2022 - Second Reading - Increase accessibility |
No | Yes |
How "We can't say anything concrete about how they voted on" is worked out
Jacinta Nampijinpa Price has only voted once on this policy and it wasn't on a "strong" vote. So it's not possible to draw a clear conclusion about their position.
This could be because there were simply not many relevant divisions (formal votes) during the time they've been in parliament (most votes happen on "the voices", so we simply have no decent record) or they were absent for votes that could have contributed to their voting record.